Patents by Inventor Finn Olav Levy

Finn Olav Levy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-HT4 receptor antagonists for the treatment of heart failure
    Patent number: 8829028
    Abstract: This invention provides the use of a 5-HT4 receptor antagonist in the manufacture of a medicament for treating or preventing heart failure. Particular heart disorders to be treated are selected from the group comprising chronic heart failure, congestive heart failure, chronic congestive heart failure and heart failure resulting from ischaemic heart disease. Methods of treating heart failure using 5-HT4 receptor antagonists and pharmaceutical compositions containing 5-HT4 receptor antagonists are also provided.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: September 9, 2014
    Assignee: Serodus AS
    Inventor: Finn Olav Levy
  • 5-HT RECEPTOR MODULATING COMPOUNDS
    Publication number: 20120094989
    Abstract: The present invention relates to compounds having 5-hydroxytryptamine receptor modulating activity, in particular compounds having an acidic moiety held distant from the 5-HT pharmacophore by a rigid linker group, to compositions containing such compounds and methods of treatment using them. Such compounds have an increased affinity for the 5-HT receptor and a reduced hERG effect. Certain compounds of the invention further exhibit an angiotensin II receptor modulating activity. Claimed are compounds of formula (I): HT-L-A. HT is a 5-HT receptor modulating moiety containing a basic nitrogen atom; A is an acid moiety; L is a linker moiety.
    Type: Application
    Filed: April 1, 2010
    Publication date: April 19, 2012
    Applicant: SERODUS AS
    Inventors: Jo Klaveness, Bjame Brudeli, Finn Olav Levy, Lise Roman Moltzau, Trygve Gulbrandsen
  • Modulators of peripheral 5-HT receptors
    Patent number: 7834010
    Abstract: The invention relates to modulators of peripheral 5-HT receptors, particularly 5-HT4 receptors, said modulators essentially selective for peripheral 5-HT receptors over receptors of the central nervous system. The invention allows for the treatment, amongst others, of gastrointestinal disorders, lower urinary tract disorders, and cardiovascular disorders without side effects related to CNS activity.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: November 16, 2010
    Assignee: Serodus AS
    Inventors: Jo Klaveness, Finn Olav Levy, Bjarne Brudeli
  • 5-HT4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEART FAILURE
    Publication number: 20090169545
    Abstract: This invention provides the use of a 5-HT4 receptor antagonist in the manufacture of a medicament for treating or preventing heart failure. Particular heart disorders to be treated are selected from the group comprising chronic heart failure, congestive heart failure, chronic congestive heart failure and heart failure resulting from ischaemic heart disease. Methods of treating heart failure using 5-HT4 receptor antagonists and pharmaceutical compositions containing 5-HT4 receptor antagonists are also provided.
    Type: Application
    Filed: February 17, 2009
    Publication date: July 2, 2009
    Applicant: SERODUS AS
    Inventor: FINN OLAV LEVY
  • 5-HTX MODULATORS
    Publication number: 20090029979
    Abstract: This invention relates to compounds which bind to serotonin receptors inside or outside the central nervous system, in particular compounds which bind to the 5-HT2 or 5-HT7 receptors, their preparation and use, compositions containing them, and methods of treatment using them.
    Type: Application
    Filed: July 7, 2006
    Publication date: January 29, 2009
    Applicant: BIO-MEDISINSK INNOVASJON AS
    Inventors: Jo Klaveness, Bjarne Brudeli, Finn Olav Levy